Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Martin J. Hessner PhD

Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Endocrinology


Publications

  • Diubiquitin (Ubd) is a susceptibility gene for virus-triggered autoimmune diabetes in rats. (Cort L, Habib M, Eberwine RA, Hessner MJ, Mordes JP, Blankenhorn EP) Genes Immun 2014 Jan 23: PMID 24452267
  • Host Microarray Molecular Signature and Serologic Evaluation of Stages of Pseudomonas aeruginosa Infection in Cystic Fibrosis. (Levy H, Reske M, Bersie R, Barbieri J, Jia S, Kaldunski M, Simpson P, Laxova A, Farrell PM, Hessner MJ) Ann Am Thorac Soc 2014 Jan;11 Suppl 1:S80-1 PMID 24437430
  • Gene targeting in NOD mouse embryos using zinc-finger nucleases. (Chen YG, Forsberg MH, Khaja S, Ciecko AE, Hessner MJ, Geurts AM) Diabetes 2014 Jan;63(1):68-74 PMID 23974926
  • Temporal induction of immunoregulatory processes coincides with age-dependent resistance to viral-induced type 1 diabetes. (Chen YG, Mordes JP, Blankenhorn EP, Kashmiri H, Kaldunski ML, Jia S, Geoffrey R, Wang X, Hessner MJ) Genes Immun 2013 Sep;14(6):387-400 PMID 23739610
  • Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. (Christy AL, Walker ME, Hessner MJ, Brown MA) J Autoimmun 2013 May;42:50-61 PMID 23267561
  • IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy. (Schmitt EG, Haribhai D, Williams JB, Aggarwal P, Jia S, Charbonnier LM, Yan K, Lorier R, Turner A, Ziegelbauer J, Georgiev P, Simpson P, Salzman NH, Hessner MJ, Broeckel U, Chatila TA, Williams CB) J Immunol 2012 Dec 15;189(12):5638-48 PMID 23125413
  • Biobreeding rat islets exhibit reduced antioxidative defense and N-acetyl cysteine treatment delays type 1 diabetes. (Bogdani M, Henschel AM, Kansra S, Fuller JM, Geoffrey R, Jia S, Kaldunski ML, Pavletich S, Prosser S, Chen YG, Lernmark A, Hessner MJ) J Endocrinol 2013 Feb;216(2):111-23 PMID 23111281
  • Transcriptional signatures as a disease-specific and predictive inflammatory biomarker for type 1 diabetes. (Levy H, Wang X, Kaldunski M, Jia S, Kramer J, Pavletich SJ, Reske M, Gessel T, Yassai M, Quasney MW, Dahmer MK, Gorski J, Hessner MJ) Genes Immun 2012 Dec;13(8):593-604 PMID 22972474
  • Predicting disease-related subnetworks for type 1 diabetes using a new network activity score. (Gao S, Jia S, Hessner MJ, Wang X) OMICS 2012 Oct;16(10):566-78 PMID 22917479
  • Requirements for growth and IL-10 expression of highly purified human T regulatory cells. (Bonacci B, Edwards B, Jia S, Williams CB, Hessner MJ, Gauld SB, Verbsky JW) J Clin Immunol 2012 Oct;32(5):1118-28 PMID 22562448
  • A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. (Haribhai D, Williams JB, Jia S, Nickerson D, Schmitt EG, Edwards B, Ziegelbauer J, Yassai M, Li SH, Relland LM, Wise PM, Chen A, Zheng YQ, Simpson PM, Gorski J, Salzman NH, Hessner MJ, Chatila TA, Williams CB) Immunity 2011 Jul 22;35(1):109-22 PMID 21723159
  • Use of transcriptional signatures induced in lymphoid and myeloid cell lines as an inflammatory biomarker in Type 1 diabetes. (Jia S, Kaldunski M, Jailwala P, Geoffrey R, Kramer J, Wang X, Hessner MJ) Physiol Genomics 2011 Jun 15;43(11):697-709 PMID 21406607
  • Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. (Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B, Serpe JM, Dasu T, Tschannen MR, Veith RL, Basehore MJ, Broeckel U, Tomita-Mitchell A, Arca MJ, Casper JT, Margolis DA, Bick DP, Hessner MJ, Routes JM, Verbsky JW, Jacob HJ, Dimmock DP) Genet Med 2011 Mar;13(3):255-62 PMID 21173700
  • Global analysis of phase locking in gene expression during cell cycle: the potential in network modeling. (Gao S, Hartman JL 4th, Carter JL, Hessner MJ, Wang X) BMC Syst Biol 2010;4:167 PMID 21129191
  • Characterization of soy-based changes in Wnt-frizzled signaling in prostate cancer. (Liss MA, Schlicht M, Kahler A, Fitzgerald R, Thomassi T, Degueme A, Hessner M, Datta MW) Cancer Genomics Proteomics 2010 Sep-Oct;7(5):245-52 PMID 20952759
  • Geno-transcriptomic dissection of proteinuria in the uninephrectomized rat uncovers a molecular complexity with sexual dimorphism. (Yagil Y, Hessner M, Schulz H, Gosele C, Lebedev L, Barkalifa R, Sapojnikov M, Hubner N, Yagil C) Physiol Genomics 2010 Nov 29;42A(4):301-16 PMID 20876844
  • Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice. (Kerschen E, Hernandez I, Zogg M, Jia S, Hessner MJ, Fernandez JA, Griffin JH, Huettner CS, Castellino FJ, Weiler H) J Clin Invest 2010 Sep;120(9):3167-78 PMID 20714108
  • Identification of a serum-induced transcriptional signature associated with type 1 diabetes in the BioBreeding rat. (Kaldunski M, Jia S, Geoffrey R, Basken J, Prosser S, Kansra S, Mordes JP, Lernmark A, Wang X, Hessner MJ) Diabetes 2010 Oct;59(10):2375-85 PMID 20682698
  • Use of cross species genomic profiling identifies pathways and genes differentially regulated in prostate cancer cells treated with soy protein isolates or purified genistein. (Liss MA, Schlicht M, Degueme A, Hessner M, Datta MW) Cancer Genomics Proteomics 2010 May-Jun;7(3):111-28 PMID 20551244
  • Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses. (Das R, Komorowski R, Hessner MJ, Subramanian H, Huettner CS, Cua D, Drobyski WR) Blood 2010 Jun 24;115(25):5249-58 PMID 20382845
  • Differential effects of leptin receptor mutation on male and female BBDR Gimap5-/Gimap5- spontaneously diabetic rats. (Moralejo DH, Hansen CT, Treuting P, Hessner MJ, Fuller JM, Van Yserloo B, Jensen R, Osborne W, Kwitek AE, Lernmark A) Physiol Genomics 2010 Mar 3;41(1):9-20 PMID 19996157
  • MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin. (Chen F, Zhang G, Cao Y, Hessner MJ, See WA) J Urol 2009 Dec;182(6):2932-7 PMID 19853870
  • Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation. (Jailwala P, Waukau J, Glisic S, Jana S, Ehlenbach S, Hessner M, Alemzadeh R, Matsuyama S, Laud P, Wang X, Ghosh S) PLoS One 2009;4(8):e6527 PMID 19654878
  • An autoinflammatory disease due to homozygous deletion of the IL1RN locus. (Reddy S, Jia S, Geoffrey R, Lorier R, Suchi M, Broeckel U, Hessner MJ, Verbsky J) N Engl J Med 2009 Jun 4;360(23):2438-44 PMID 19494219
  • Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. (Chen X, Das R, Komorowski R, Beres A, Hessner MJ, Mihara M, Drobyski WR) Blood 2009 Jul 23;114(4):891-900 PMID 19491393
  • Quality Weighted Mean and T-test in Microarray Analysis Lead to Improved Accuracy in Gene Expression Measurements and Reduced Type I and II Errors in Differential Expression Detection. (Gao S, Jia S, Hessner M, Wang X) J Comput Sci Syst Biol 2008 Dec 26;1:41 PMID 20151041
  • Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease. (Das R, Chen X, Komorowski R, Hessner MJ, Drobyski WR) Blood 2009 Mar 5;113(10):2352-62 PMID 19059877
  • Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5. (Schulteis RD, Chu H, Dai X, Chen Y, Edwards B, Haribhai D, Williams CB, Malarkannan S, Hessner MJ, Glisic-Milosavljevic S, Jana S, Kerschen EJ, Ghosh S, Wang D, Kwitek AE, Lernmark A, Gorski J, Weiler H) Blood 2008 Dec 15;112(13):4905-14 PMID 18796632
  • Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. (Wang X, Jia S, Geoffrey R, Alemzadeh R, Ghosh S, Hessner MJ) J Immunol 2008 Feb 1;180(3):1929-37 PMID 18209091
  • Molecular targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) within the zebrafish ovary: insights into TCDD-induced endocrine disruption and reproductive toxicity. (Heiden TC, Struble CA, Rise ML, Hessner MJ, Hutz RJ, Carvan MJ 3rd) Reprod Toxicol 2008 Jan;25(1):47-57 PMID 17884332
  • Quantitative measurement of pathogen-specific human memory T cell repertoire diversity using a CDR3 beta-specific microarray. (Wang X, Jia S, Meyer L, Yassai MB, Naumov YN, Gorski J, Hessner MJ) BMC Genomics 2007;8:329 PMID 17880719
  • Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat. (Geoffrey R, Jia S, Kwitek AE, Woodliff J, Ghosh S, Lernmark A, Wang X, Hessner MJ) J Immunol 2006 Nov 15;177(10):7275-86 PMID 17082646
  • Comprehensive quality control utilizing the prehybridization third-dye image leads to accurate gene expression measurements by cDNA microarrays. (Wang X, Jia S, Meyer L, Xiang B, Chen LY, Jiang N, Moreno C, Jacob HJ, Ghosh S, Hessner MJ) BMC Bioinformatics 2006;7:378 PMID 16907976
  • The application of microarray analysis to pediatric diseases. (Hessner MJ, Liang M, Kwitek AE) Pediatr Clin North Am 2006 Aug;53(4):579-90 PMID 16872994
  • Three-color cDNA microarrays with prehybridization quality control yield gene expression data comparable to that of commercial platforms. (Hessner MJ, Xiang B, Jia S, Geoffrey R, Holmes S, Meyer L, Muheisen S, Wang X) Physiol Genomics 2006 Mar 13;25(1):166-78 PMID 16403843
  • Transcriptome analysis and kidney research: toward systems biology. (Liang M, Cowley AW Jr, Hessner MJ, Lazar J, Basile DP, Pietrusz JL) Kidney Int 2005 Jun;67(6):2114-22 PMID 15882254
  • Involvement of eotaxin, eosinophils, and pancreatic predisposition in development of type 1 diabetes mellitus in the BioBreeding rat. (Hessner MJ, Wang X, Meyer L, Geoffrey R, Jia S, Fuller J, Lernmark A, Ghosh S) J Immunol 2004 Dec 1;173(11):6993-7002 PMID 15557196
  • Leucine culture reveals that ATP synthase functions as a fuel sensor in pancreatic beta-cells. (Yang J, Wong RK, Wang X, Moibi J, Hessner MJ, Greene S, Wu J, Sukumvanich S, Wolf BA, Gao Z) J Biol Chem 2004 Dec 24;279(52):53915-23 PMID 15489222
  • A novel approach for high-quality microarray processing using third-dye array visualization technology. (Wang X, Jiang N, Feng X, Xie Y, Tonellato PJ, Ghosh S, Hessner MJ) IEEE Trans Nanobioscience 2003 Dec;2(4):193-201 PMID 15376909
  • Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium. (Schlicht M, Matysiak B, Brodzeller T, Wen X, Liu H, Zhou G, Dhir R, Hessner MJ, Tonellato P, Suckow M, Pollard M, Datta MW) BMC Genomics 2004 Aug 20;5(1):58 PMID 15318950
  • Immobilized probe and glass surface chemistry as variables in microarray fabrication. (Hessner MJ, Meyer L, Tackes J, Muheisen S, Wang X) BMC Genomics 2004 Aug 4;5(1):53 PMID 15294027
  • B.E.A.R. GeneInfo: a tool for identifying gene-related biomedical publications through user modifiable queries. (Zhou G, Wen X, Liu H, Schlicht MJ, Hessner MJ, Tonellato PJ, Datta MW) BMC Bioinformatics 2004 Apr 29;5:46 PMID 15117422
  • Detection of genomic polymorphisms associated with venous thrombosis using the invader biplex assay. (Patnaik M, Dlott JS, Fontaine RN, Subbiah MT, Hessner MJ, Joyner KA, Ledford MR, Lau EC, Moehlenkamp C, Amos J, Zhang B, Williams TM) J Mol Diagn 2004 May;6(2):137-44 PMID 15096570
  • Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response. (Morrison J, Knoll K, Hessner MJ, Liang M) Physiol Genomics 2004 May 19;17(3):271-82 PMID 15039483
  • Utilization of a labeled tracking oligonucleotide for visualization and quality control of spotted 70-mer arrays. (Hessner MJ, Singh VK, Wang X, Khan S, Tschannen MR, Zahrt TC) BMC Genomics 2004 Feb 9;5(1):12 PMID 15018646
  • Difference in gene expression profiles between human CD4+CD25+ and CD4+CD25- T cells. (Pati N, Ghosh S, Hessner MJ, Khoo HJ, Wang X) Ann N Y Acad Sci 2003 Nov;1005:279-83 PMID 14679076
  • The design of a gene chip for functional immunological studies on a high-quality control platform. (Waukau J, Jailwala P, Wang Y, Khoo HJ, Ghosh S, Wang X, Hessner MJ) Ann N Y Acad Sci 2003 Nov;1005:284-7 PMID 14679077
  • Quantitative quality control in microarray experiments and the application in data filtering, normalization and false positive rate prediction. (Wang X, Hessner MJ, Wu Y, Pati N, Ghosh S) Bioinformatics 2003 Jul 22;19(11):1341-7 PMID 12874045
  • Use of a three-color cDNA microarray platform to measure and control support-bound probe for improved data quality and reproducibility. (Hessner MJ, Wang X, Khan S, Meyer L, Schlicht M, Tackes J, Datta MW, Jacob HJ, Ghosh S) Nucleic Acids Res 2003 Jun 1;31(11):e60 PMID 12771224
  • Three color cDNA microarrays: quantitative assessment through the use of fluorescein-labeled probes. (Hessner MJ, Wang X, Hulse K, Meyer L, Wu Y, Nye S, Guo SW, Ghosh S) Nucleic Acids Res 2003 Feb 15;31(4):e14 PMID 12582259
  • Rh genotyping: avoiding false-negative and false-positive results among individuals of African ancestry. (Ekman GC, Billingsly R, Hessner MJ) Am J Hematol 2002 Jan;69(1):34-40 PMID 11835329
  • Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity. (Raife TJ, Lentz SR, Atkinson BS, Vesely SK, Hessner MJ) Blood 2002 Jan 15;99(2):437-42 PMID 11781222
  • Multisite study for genotyping of the factor II (prothrombin) G20210A mutation by the invader assay. (Hessner MJ, Friedman KD, Voelkerding KV, Huber S, Ryan D, Nuccie B, Ledford M) Clin Chem 2001 Nov;47(11):2048-50 PMID 11673380
  • Age-dependent prevalence of vascular disease-associated polymorphisms among 2689 volunteer blood donors. (Hessner MJ, Dinauer DM, Kwiatkowski R, Neri B, Raife TJ) Clin Chem 2001 Oct;47(10):1879-84 PMID 11568114
  • Antigenic characterization of medullary carcinoma of the breast: HLA-DR expression in lymph node positive cases. (Lazzaro B, Anderson AE, Kajdacsy-Balla A, Hessner MJ) Appl Immunohistochem Mol Morphol 2001 Sep;9(3):234-41 PMID 11556751
  • A multi-site study for detection of the factor V (Leiden) mutation from genomic DNA using a homogeneous invader microtiter plate fluorescence resonance energy transfer (FRET) assay. (Ledford M, Friedman KD, Hessner MJ, Moehlenkamp C, Williams TM, Larson RS) J Mol Diagn 2000 May;2(2):97-104 PMID 11272895
  • Prenatal Genotyping of the RhD Locus to Identify Fetuses at Risk for Hemolytic Disease of the Newborn. (Hessner MJ, Bellissimo DB) Methods Mol Med 2001;49:427-37 PMID 21370158
  • Quantitative evaluation of post-bone marrow transplant engraftment status using fluorescent-labeled variable number of tandem repeats. (Luhm RA, Bellissimo DB, Uzgiris AJ, Drobyski WR, Hessner MJ) Mol Diagn 2000 Jun;5(2):129-38 PMID 11066014
  • The C536T transition in the tissue factor pathway inhibitor (TFPI) gene does not contribute to risk of venous thrombosis among carriers of factor V Leiden. (Hessner MJ, Luhm RA) Thromb Haemost 2000 Oct;84(4):724-5 PMID 11057878
  • Blood group A and B antigens are strongly expressed on platelets of some individuals. (Curtis BR, Edwards JT, Hessner MJ, Klein JP, Aster RH) Blood 2000 Aug 15;96(4):1574-81 PMID 10942408
  • Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes. (Hessner MJ, Budish MA, Friedman KD) Clin Chem 2000 Aug;46(8 Pt 1):1051-6 PMID 10926882
  • Screening of six racial groups for the intron 5 G-->A 3' splice acceptor mutation responsible for the polynesian kidd (a-b-) phenotype: the null mutation is not always associated with the JKB allele. (Ekman GC, Hessner MJ) Transfusion 2000 Jul;40(7):888-9 PMID 10924622
  • Sequence-based typing of HLA class II DQB1. (Dinauer DM, Luhm RA, Uzgiris AJ, Eckels DD, Hessner MJ) Tissue Antigens 2000 Apr;55(4):364-8 PMID 10852389
  • Allelic distribution of the glycoprotein Ia (alpha2-integrin) C807T/G873A dimorphisms among caucasian venous thrombosis patients and six racial groups. (Dinauer DM, Friedman KD, Hessner MJ) Br J Haematol 1999 Dec;107(3):563-5 PMID 10583259
  • Contribution of the glycoprotein Ia 807TT, methylene tetrahydrofolate reductase 677TT and prothrombin 20210GA genotypes to prothrombotic risk among factor V 1691GA (Leiden) carriers. (Hessner MJ, Dinauer DM, Luhm RA, Endres JL, Montgomery RR, Friedman KD) Br J Haematol 1999 Jul;106(1):237-9 PMID 10444193
  • T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation. (Drobyski WR, Hessner MJ, Klein JP, Kabler-Babbitt C, Vesole DH, Margolis DA, Keever-Taylor CA) Blood 1999 Jul 15;94(2):434-41 PMID 10397710
  • Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. (Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR) Thromb Haemost 1999 May;81(5):733-8 PMID 10365746
  • Prenatal genotyping of the Duffy blood group system by allele-specific polymerase chain reaction. (Hessner MJ, Pircon RA, Johnson ST, Luhm RA) Prenat Diagn 1999 Jan;19(1):41-5 PMID 10073905
  • Neutrophil antigen (FcgammaRIIIB) SH gene frequencies in six racial groups. (Hessner MJ, Shivaram SM, Dinauer DM, Curtis BR, Endean DJ, Aster RH) Blood 1999 Feb 1;93(3):1115-6 PMID 10025985
  • Prenatal genotyping of Jk(a) and Jk(b) of the human Kidd blood group system by allele-specific polymerase chain reaction. (Hessner MJ, Pircon RA, Johnson ST, Luhm RA) Prenat Diagn 1998 Dec;18(12):1225-31 PMID 9885013
  • The use of the polymerase chain reaction to predict for subsequent relapse in unrelated marrow transplantation for chronic myelogenous leukemia. (Drobyski WR, Hessner MJ) Leuk Lymphoma 1998 Oct;31(3-4):317-23 PMID 9869195
  • Successful unrelated marrow transplantation for patients over the age of 40 with chronic myelogenous leukemia. (Drobyski WR, Pelz C, Kabler-Babbitt C, Hessner M, Baxter-Lowe LA, Keever-Taylor CA) Biol Blood Marrow Transplant 1998;4(1):3-12 PMID 9701386
  • T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up. (Juckett M, Rowlings P, Hessner M, Keever-Taylor C, Burns W, Camitta B, Casper J, Drobyski WR, Hanson G, Horowitz M, Lawton C, Margolis J, Peitryga D, Vesole D) Bone Marrow Transplant 1998 May;21(9):893-9 PMID 9613781
  • A(1,2)BO(1,2) genotyping by multiplexed allele-specific PCR. (Pearson SL, Hessner MJ) Br J Haematol 1998 Jan;100(1):229-34 PMID 9450817
  • Detection of BCR/ABL RNA transcripts using the polymerase chain reaction is highly predictive for relapse in patients transplanted with unrelated marrow grafts for chronic myelogenous leukaemia. (Drobyski WR, Endean DJ, Klein JP, Hessner MJ) Br J Haematol 1997 Aug;98(2):458-66 PMID 9266951
  • The sensitivity of allele-specific polymerase chain reaction can obviate concern of maternal contamination when fetal samples are genotyped for immune cytopenic disorders. (Hessner MJ, Agostini TA, Bellissimo DB, Endean DJ, Pircon RA, Kirschbaum NE) Am J Obstet Gynecol 1997 Feb;176(2):327-33 PMID 9065176
  • Determination of neutrophil antigen gene frequencies in five ethnic groups by polymerase chain reaction with sequence-specific primers. (Hessner MJ, Curtis BR, Endean DJ, Aster RH) Transfusion 1996 Oct;36(10):895-9 PMID 8863777
  • Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers. (Hessner MJ, McFarland JG, Endean DJ) Transfusion 1996 Jun;36(6):495-9 PMID 8669079
  • Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia. (Hessner MJ, Endean DJ, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M, Flomenberg N, Drobyski WR) Blood 1995 Nov 15;86(10):3987-96 PMID 7579370
  • Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers. (Skogen B, Bellissimo DB, Hessner MJ, Santoso S, Aster RH, Newman PJ, McFarland JG) Transfusion 1994 Nov-Dec;34(11):955-60 PMID 7526491
  • Development of a sensitive, highly controlled assay for molecular detection of the Philadelphia chromosome in patients with chronic myelogenous leukemia. (Hessner MJ, Roth MS, Drobyski WR, Baxter-Lowe LA) Genet Anal Tech Appl 1994;11(4):90-4 PMID 7857690
  • Characterization of novel HLA-DPB1 alleles by oligotyping and nucleotide sequencing. (Hessner MJ, Baxter-Lowe LA) Tissue Antigens 1992 Nov;40(5):261-3 PMID 1481203
  • Construction, characterization, and complementation of Rhodospirillum rubrum puf region mutants. (Hessner MJ, Wejksnora PJ, Collins ML) J Bacteriol 1991 Sep;173(18):5712-22 PMID 1715861
  • Grants and Awards

  • Quantitative Measurement of T1D Risk Through Molecular Signature Analysis (#9207969 04/05/2013 - 03/31/2016) Sponsor: NIH Diabetes, Digestive and Kidney Diseases
  • Serum/Plasma Induced Signatures as T1D Biomarkers (#9207614 07/01/2012 - 06/30/2015) Sponsor: American Diabetes Association
  • Quantitative Assessment of T1D Risk through Molecular Signature Analysis (#9207712 10/01/2012 - 09/30/2014) Sponsor: Juvenile Diabetes Research Foundation Internationa
  • Robust T-Cell Immunity to Influenza in Human Populations (#9204784 09/01/2007 - 08/31/2008) Sponsor: BloodCenter of Wisconsin
  • High Density Microarrays With Quantitative QC/QA (#9202971 08/01/2003 - 06/30/2008) Sponsor: NIH Biomedical Imaging and Bioengineering
  • Circulating Beta Cell-derived DNA as a Biomarker of Beta Cell Loss in T1D (#9208321 10/01/2013 - 09/30/2014) Sponsor: Winthrop University Hospital
  • Dissection of Cellular Interactions With Integrated Functional Genomics in Comple (#9205462 01/01/2009 - 12/31/2014) Sponsor: NIH Allergy and Infectious Diseases